Moxifloxacin

Product manufactured by Direct Rx

Application Nr Approved Date Route Status External Links
ANDA090080 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Moxifloxacin Ophthalmic Solution Is Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Corynebacterium Species* Micrococcus Luteus* Staphylococcus Aureus Staphylococcus Epidermidis Staphylococcus Haemolyticus Staphylococcus Hominis Staphylococcus Warneri* Streptococcus Pneumoniae Streptococcus Viridans Group Acinetobacter Lwoffii* Haemophilus Influenza Haemophilus Parainfluenzae* Chlamydia Trachomatis *efficacy For This Organism Was Studied In Fewer Than 10 Infections.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Moxifloxacin Hydrochloride Monohydrate

Comments